Adrenal computed tomography and NP-59 usefulness for diagnosing aldosterone-producing adenomas and idiopathic hyperaldosteronism in primary hyperaldosteronism  by Lin, Ting-Po et al.
lable at ScienceDirect
Urological Science xxx (2015) 1e5Contents lists avaiUrological Science
journal homepage: www.urol-sci .comOriginal articleAdrenal computed tomography and NP-59 usefulness for diagnosing
aldosterone-producing adenomas and idiopathic hyperaldosteronism
in primary hyperaldosteronism
Ting-Po Lin a, Allen W. Chiu b, Marcelo Chen a, Che-Hao Weng a, Pei-Yin Ho c,
Jong-Ming Hsu a, Wun-Rong Lin a, *
a Department of Urology, Mackay Memorial Hospital, Taipei, Taiwan
b School of Medicine, National Yang-Ming University, Taipei, Taiwan
c Graduate Institute of Oncology, National Taiwan University, Taipei, Taiwana r t i c l e i n f o
Article history:
Received 14 January 2014
Received in revised form
11 February 2014
Accepted 21 July 2014
Available online xxx
Keywords:
adrenal adenoma
adrenal venous sampling
idiopathic hyperaldosteronism
NP-59 adrenal scintigraphy
primary aldosteronism* Corresponding author. Department of Urology,
Number 92, Section 2, Zhongshan North Road, Zhong
Taiwan.
E-mail address: cedric305@gmail.com (W.-R. Lin).
http://dx.doi.org/10.1016/j.urols.2014.07.010
1879-5226/Copyright © 2015, Taiwan Urological Asso
Please cite this article in press as: Lin T-P, e
adenomas and idiopathic hyperaldostero
j.urols.2014.07.010a b s t r a c t
Objectives: Two major causes of primary aldosteronism are aldosterone-producing adenomas (APA) and
idiopathic hyperaldosteronism (IHA). In this study, we attempted to determine the role of NP-59 in
identifying APA prior to adrenalectomy, especially when diagnostic computer tomography (CT) is
equivocal.
Methods: We performed a retrospective analysis in patients with a clinical diagnosis of primary aldo-
steronism. The medical records of 36 patients were reviewed, which included 25 patients who had
received adrenalectomy. All patients underwent adrenal CT alone or a combination of adrenal CT and NP-
59 prior to surgery for the subtyping of primary aldosteronism, based on the protocols established in our
institution. The accuracy of the adrenal CT and NP-59 ﬁndings was determined by a comparison with the
pathologic ﬁndings and postoperative outcomes.
Results: Twenty-three patients received unilateral adrenalectomy under the diagnosis of APA. The di-
agnoses were based on CT ﬁndings in 11 patients and on CT and NP-59 ﬁndings in 12 patients. The results
of pathology were adrenal cortical adenoma in these 23 patients and the positive predictive value was
100%. Blood pressure and potassium levels signiﬁcantly improved after surgery in these patients
(p < 0.01). Serum biochemistry and adrenal size of the limbs and bodies of patients with IHA were not
signiﬁcantly different from those of patients with APA.
Conclusion: For the subtyping of primary aldosteronism, the imaging modality of adrenal CT alone or the
combination of adrenal CT and NP-59 adrenal scan has a high positive predictive value for APAs. We
suggest that all patients undergo an adrenal CT as their initial study, after conﬁrming the diagnosis of
primary aldosteronism, and to use NP-59 when adrenal CT ﬁndings are atypical or inconclusive. Later-
alization by this modality prior to adrenalectomy can reduce unnecessarily invasive examinations such as
adrenal venous sampling and also provide excellent treatment outcomes.
Copyright © 2015, Taiwan Urological Association. Published by Elsevier Taiwan LLC. All rights reserved.1. Introduction
Primary aldosteronism is a group of disorders in which aldo-
sterone production is inappropriately high. The disorder results in
hypertension and hypokalemia.1 The incidence of primaryMackay Memorial Hospital,
shan District, Taipei City 104,
ciation. Published by Elsevier Taiw
t al., Adrenal computed tomo
nism in primary hyperaldaldosteronism is much higher than previously thought.2 There are
two major causes of primary aldosteronism: aldosterone-
producing adenomas (APAs) and idiopathic hyperaldosteronism
(IHA). Differentiating between these two causes is important
because an APA is treated surgically, whereas idiopathic hyper-
aldosteronism is generally managed medically.
Biochemical differentiation for the subtype classiﬁcation of
primary aldosteronism is usually imprecise.3 Adrenal computer
tomography (CT) is recommended as the initial study to determine
the subtype and exclude adrenocortical carcinoma.1 However, poor
speciﬁcity limits its use in decision-making. [Iodine-131]6-beta-an LLC. All rights reserved.
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essentially captured by low-density lipoprotein (LDL) receptors in
the adrenal glands.4 NP-59 scintigraphy of the adrenal cortex can be
used to correlate functional and anatomical abnormalities, but it is
rarely used because of its poor sensitivity.5 The NP-59 scan is not
useful for evaluating small adrenal nodules because tracer uptake is
poor in APAs <1.5 cm in diameter.6 Bilateral adrenal venous sam-
pling is considered the gold standard in lateralizing aldosterone
hypersecretion; to avoid inappropriate operations, it should be
performed prior to any surgical treatment.1 However, adrenal
venous sampling is invasive and operator-dependent. Success rates
vary in part with local expertise.
In this study, we attempted to determine whether NP-59 scin-
tigraphy in patients who had equivocal CT ﬁndings could provide a
high positive predictive value for identifying APAs, especially in a
subgroup of patients undergoing unilateral adrenalectomy.
2. Methods
We performed a retrospective analysis of patients who received
a clinical diagnosis of primary aldosteronism from 2003 to 2013.
Thirty-six patients were eligible for the study and were then
reviewed. The research protocol was approved by the Institutional
Review Board of Mackay Memorial Hospital (Taipei, Taiwan). Pa-
tient privacy and conﬁdentiality were protected by the de-
identiﬁcation of all information. Clinical characteristics, labora-
tory studies, preoperative images, surgical treatment, pathology
results, and postoperative outcomes were all recorded. Primary
aldosteronism was diagnosed, based on the clinical ﬁndings of
hypertension, increased aldosterone concentration, and suppressed
plasma renin activity. All patients had a plasma aldosterone-to-
renin ratio >50.
After conﬁrming the diagnosis of primary aldosteronism, all
patients underwent adrenal CT as the initial approach to localiza-
tion. Images were reviewed by an experienced radiologist (P.S. Tsai)
and patients were classiﬁed as having APA, IHA, or as inconclusive
by radiologic characteristics. A CT diagnosis of adenoma was based
on the presence of a single, well-deﬁned, hypodense, and macro-
nodular lesion with a normal appearance in the remaining ipsilat-
eral and contralateral adrenal gland, whereas a diagnosis of
hyperplasia was based on the presence of symmetric and enlarged
adrenal glands. The results were inconclusive if the adrenal glandsFig. 1. Abdominal computer tomography of a 51-year-old female shows a 1.5 cm  0.9 cm n
delayed ﬁlms, which is more in favor of an adenoma. NP-59 was arranged; it showed early vi
adrenalectomy. Pathology conﬁrmed an adrenocortical adenoma.
Please cite this article in press as: Lin T-P, et al., Adrenal computed tomo
adenomas and idiopathic hyperaldosteronism in primary hyperald
j.urols.2014.07.010appeared normal or if CT imaging showed focal or unilateral ad-
renal limb thickening, unilateral adrenal micronodules, bilateral
macronodules, or atypical nodular lesions. Based on the radiolo-
gist's experience, the inconclusive group was further subclassiﬁed
into “suspected APA” and “suspected IHA.” The size of the adrenal
glands was also measured by the radiologist who measured the
maximal adrenal gland body and limb widths for every gland.
If the adrenal CT ﬁndings were equivocal, NP-59 scintigraphy
was performed to conﬁrm the diagnosis. From 2 days prior to the
NP-59 injection to 6 days after, 0.5 mg dexamethasone was
administered orally four times daily to suppress nonautonomous
adrenocortical activity. Patients then received an injection of 1 mCi
of radiolabeled cholesterol. Planar imaging was started 3 days after
the injection. Patients underwent ﬁnal imaging 7 days after injec-
tion. Unilateral or highly asymmetric uptake on Days 3e5 was
suggestive of an adenoma. The results of NP-59 were interpreted by
experienced nuclear medicine physicians (M.Z. Wu, B.F. Shi, Q.H.
Cao, and G.H. Lin).
Patients with a deﬁnite diagnosis of APA (based on CT) or sus-
pected APA (based on both CT and NP-59) underwent unilateral
adrenalectomy (Fig. 1). The ﬁnal diagnosis of APA was based on the
histopathological examination of the specimen. By contrast, IHA
was diagnosed by radiologic ﬁndings or suspected ﬁndings on both
CT and NP-59. If ﬁndings of NP-59 scan and adrenal CT were
inconsistent, further adrenal venous sampling or surgery was per-
formed in accordance with the patient's choices (Fig. 2).
The primary aim of our studywas to compare the adrenal CTand
NP-59 ﬁndings with the pathologic diagnosis. Clinical outcomes
included systolic blood pressure measurements and use of anti-
hypertensive drugs. Biochemical outcome included serum potas-
sium level and plasma aldosterone and renin levels. The patients'
hypertension was categorized as “cured”, “improved”, or “not
improved.” Hypokalemia was considered cured if the serum po-
tassium level returned to the normal range without any regular
potassium supplementation. The follow-up period was deﬁned
from the operative date to the latest urologic or endocrinologic
outpatient department visit.
In the statistical analysis, all data were expressed as mean± SD.
The Student two-sample t test for normally distributed variables
was performed on various data sets, and p < 0.05 was considered
statistically signiﬁcant. The statistical analysis was performed using
SPSS version 1.2 software (SPSS Inc., Chicago, IL, USA).odular lesion in the right adrenal gland with enhancement and low attenuation in the
sualization of the right adrenal gland on Day 3. The patient received a right laparoscopic
graphy and NP-59 usefulness for diagnosing aldosterone-producing
osteronism, Urological Science (2015), http://dx.doi.org/10.1016/
Fig. 2. Abdominal computer tomography of a 55-year-old male shows a nodular lesion arising from the left adrenal gland. It measures approximately 1.4 cm in diameter. The
dimensions of the left adrenal gland appears to be increased in size. On Day 4, the bilateral adrenal glands are faintly visible on NP-59 scintigraphy. We arranged for adrenal venous
sampling of the patient. He was diagnosed as having idiopathic hyperaldosteronism.
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Twenty-three women and 13 men were evaluated in this study.
The mean age was 48.75± 11.0 years, the mean systolic blood
pressure prior to treatment was 170.0± 18.0 mmHg, and the mean
serum potassium level was 2.86± 0.88 mEq/L. The mean plasma
aldosterone was 507.7± 313.7 ng/dL, and the mean plasma renin
activity was 1.70± 2.23 ng/mL/h. All patients had their hyperten-
sion controlled with oral drugs. Only 27 (75%) patients presented
with hypokalemia at the initial evaluation.
All 36 patients received an adrenal CT scan. Eleven patients were
diagnosed with APA, and six patients were diagnosed with IHA.
There were 19 patients that had an inconclusive diagnosis, which
included 15 patients with suspected APA and four patients with
suspected IHA, based on adrenal CT. These 19 patients then un-
derwent NP-59 scan. Of these, 16 patients were deﬁnitively diag-
nosed on comparing the results of the adrenal CT and the NP-59
scan. The 12 patients with suspected APA on CT had unilateral
uptake on NP-59, and the other four patients with suspected IHA
had symmetric uptake. There were three patients with suspected
APA on CT who had bilateral uptake. Adrenal venous sampling wasFig. 3. Noninvasive examinations for subclassiﬁcation of primary aldosteronism. All parti
59 was performed if the CT ﬁndings were equivocal. Adrenal venous sampling or surge
Patients with a deﬁnitive diagnosis of aldosterone-producing adenoma on CT or suspe
adrenalectomy. a aldosterone-producing adenoma. b idiopathic hyperaldosteronism. AP
hyperaldosteronism.
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nosis after the adrenal CT and NP-59 study. In one patient, adrenal
venous sampling showed unilateral disease; in another patient, it
revealed bilateral disease. The third patient received an operation
directly.
Twenty-three patients were diagnosed as having APA and
received unilateral retroperitoneoscopic adrenalectomy. Final pa-
thology conﬁrmed cortical adenomas in all 23 patients. We also
performed an adrenalectomy in two patients with an inconclusive
diagnosis based on their adrenal CT and NP-59 study. One patient
was proven to have unilateral disease by adrenal venous sampling
and the pathology showed APA. The other patient underwent sur-
gery directly upon the patient's request and pathology revealed IHA
(Fig. 3).
Blood pressure and serum potassium levels signiﬁcantly
improved after adrenalectomy. In the APA group, the mean pre-
operative systolic blood pressure was 174± 12.0 mmHg and the
mean postoperative systolic blood pressure was
124.7± 12.6 mmHg (p¼ 0.001). The mean preoperative serum po-
tassium was 2.66± 0.81 mEq/L and the mean postoperative serum
potassium was 4.35± 0.32 mEq/L (p¼ 0.001). Seventeen (74%)cipants underwent adrenal computer tomography (CT) as their initial evaluation. NP-
ry was performed for further diagnosis if CT and NP-59 reports were inconsistent.
cted aldosterone-producing adenoma on both CT and NP-59 underwent unilateral
A¼ aldosterone-producing adenoma; CT¼ computed tomography; IHA¼ idiopathic
graphy and NP-59 usefulness for diagnosing aldosterone-producing
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any antihypertensive agents. The need for antihypertensive drugs
was reduced in the other six patients. In the IHA group, all patients
received long-term antihypertensive agents for hypertension con-
trol. One patient needed regular potassium supplementation at our
outpatient clinic.
A comparison of biochemical parameters between APAs and
IHAs showed that the aldosterone level was signiﬁcantly higher in
patients with APAs (581.8± 312.2 vs. 378± 153.5, p¼ 0.014), but
there were no signiﬁcant differences in blood pressure, potassium,
renin, and aldosterone-to-renin ratio. Also, radiologically there
were no signiﬁcant differences in adrenal size between the two
groups, except that the left body was larger in the IHA group
(9.12 mm vs. 12.16 mm; p¼ 0.03).4. Discussion
Primary aldosteronism is a recognized important cause of sec-
ondary hypertension. The prevalence of primary aldosteronism has
increased recently because of changes in the methods used to
detect primary aldosteronism.7 As a curative etiology, the diag-
nosing of APAs is crucial for the management of primary aldoste-
ronism. Early intervention for APA can also prevent excess
cardiovascular events.8 Lateralizing evaluation is usually performed
by adrenal CT and adrenal venous sampling; adrenal venous sam-
pling is considered the gold standard test for lateralization.1 Uni-
lateral and bilateral adrenal disease should be distinguished by
adrenal venous sampling when surgical treatment is feasible.1
Authors from the Mayo Clinic also recommend adrenal venous
sampling in older patients (> 40 years).5 However, adrenal venous
sampling is invasive and occasionally not possible. Therefore, we
used NP-59 as a noninvasive functional test for lateralization, and
demonstrated that the combination of adrenal CT and NP-59 was
highly accurate with regards to APA diagnosis.
As an initial study in subtype testing, adrenal CT can be used to
exclude adrenal malignancies and to locate macroadenomas.1
However, CT ﬁndings are frequently misleading. False positive re-
sults may lead to unnecessary adrenalectomies. There are several
reasons for these false positive results. First, nonfunctioning uni-
lateral adrenal macroadenomas are common, especially in the
elderly.9 Second, apparent adrenal microadenomas may actually
represent areas of hyperplasia.1 Third, contralateral micronodular
lesionsmay exist and result in surgical failure. False negative results
are usually because of micronodular lesions that cannot be seen on
CT scans. If CT alone were used to determine the subtype, 14.6% of
such patients would inappropriately undergo unilateral adrenal-
ectomy, which would not have been curative.10 In NP-59 scintig-
raphy of the adrenal cortex, the LDL receptors in the adrenal cortex
capture the cholesterol analog labeled with iodine-131.4 Detection
of hyperfunctional lesions requires that the normal adrenal cortex
uptake be suppressed by dexamethasone. NP-59 can detect func-
tional lesions in the adrenal cortex. Aldosterone-producing ade-
nomas often show unilateral uptake, whereas symmetric uptake is
typical in IHA.11
A major limitation of NP-59 is the resolution of planar imaging.
Small lesions < 1.5 cm in diameter may not be visible.6 This results
in false negative results during APA detection. However, Yen et al12
reported that as a lateralization modality after CT, it signiﬁcantly
improved the diagnostic accuracy in detecting APA. Based on our
experience, adrenal CTand NP-59 provide a high degree of accuracy
when diagnosing APA. The combination of these two exams could
correlate functional with anatomical abnormalities. As a result, the
positive predictive value of the imaging modalities in histologically
detecting proven APA was 100% in this study. Both the clinical andPlease cite this article in press as: Lin T-P, et al., Adrenal computed tomo
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As the gold standard diagnostic tool for primary aldosteronism,
adrenal venous sampling has disadvantages that are worth noting.
Two major problems with the procedure are its success rate and
related complications. The right adrenal vein is difﬁcult to identify
and cannulate, and the success rate varies according to local exper-
tise. The average success rate of right adrenal vein cannulation is
reportedly74%.13Withexperience, thesuccess rate canbe improved.5
Complications related to adrenal venous sampling are also common.
The complication rate varies from 1% to 10% and is dependent on
operator experience.14e16 Themost frequent complications are groin
hematoma and adrenal hemorrhage. Major complications such as
adrenal vein dissection, adrenal vein thrombus, and adrenal infarc-
tion are relatively rare. Because of these possible complications,
searching for a noninvasive alternative to adrenal venous sampling
could be of beneﬁt to clinicians and patients.
After the resection of the adenomas, there were six (26.0%)
patients whose blood pressure did not normalize and they still
required antihypertensive drugs. Stone et al report that the length
of hypertension history may affect the time to normalization of
blood pressure after an adrenalectomy in primary aldosteronism
patients.17 Therefore, a longer follow-up period is necessary in such
patients. Concurrent essential hypertension or adrenal CT misdi-
agnosis may also explain this high blood pressure after surgery.
Biochemical and radiological ﬁndings are also helpful in dis-
tinguishing APA and IHA in some reports. In general, patients with
APAs have more severe hypertension and hypokalemia; and these
patients are also younger than patients with IHA.5 Lingam et al18
report that the adrenal glands, especially the adrenal limbs, were
larger in patients with IHA. In our study, a comparison of the
biochemical and radiological ﬁndings between the two subtypes
showed a trend towards younger patients, higher blood pressure,
more severe hypokalemia, and larger adrenal glands in the APA
group. However, these differences were not statistically signiﬁcant.
There were some limitations regarding this study that should be
highlighted. First, patients with characteristics highly suggestive of
IHA did not undergo surgery; therefore, we did not have histo-
pathologic proof of the diagnosis. Thus, we could not evaluate the
false negative rate of NP-59. However, as part of the preoperative
evaluation, the imaging modalities (i.e., CT and NP-59) still had a
high positive predictive value for APAs, which could reduce un-
necessary surgeries and improve operative outcomes. Second, ad-
renal venous sampling was not performed in every patient to
conﬁrm the diagnosis. Third, the small sample size restricted the
statistical power of our study.
In conclusion, the utilization of adrenal CT alone or the combi-
nation of adrenal CT and NP-59 provided good diagnostic accuracy
for diagnosing APAs when subtyping primary aldosteronism. We
suggest that adrenal CT should be used as the ﬁrst lateralization
tool. NP-59 could be used when adrenal CT has atypical lesions or is
inconclusive. Adrenal venous sampling should only be considered if
the ﬁndings of both noninvasive imaging studies are inconsistent or
inconclusive. Biochemical and radiological features are not speciﬁc
enough to distinguish APAs from IHA.
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